Esperion initiates equity offering
Mar. 17, 2015 6:00 PM ETEsperion Therapeutics, Inc. (ESPR)By: Douglas W. House, SA News Editor2 Comments
- Esperion Therapeutics (NASDAQ:ESPR) commences a $150M public offering of common stock. Underwriters over-allotment is an additional $22.5M. Price and terms have yet to be announced.
Recommended For You
Comments (2)
Have a tip? Submit confidentially to our News team. Found a factual error? Report here.
Kitesurfer1962
18 Mar. 2015
Equity raise isn't neccessarily bad news ... they could be upgrading the balance sheet to become attractive ... but I would rather see that they go on alone and get acquired in a few years from now. This one has MASSIVE potential.
anomaly1
17 Mar. 2015
Dilution surprise of the day!